Human medicines European public assessment report (EPAR): Usgena, ustekinumab, Status: Opinion
Human medicines European public assessment report (EPAR): Xbonzy, denosumab, Status: Opinion
Human medicines European public assessment report (EPAR): Zvogra, denosumab, Status: Opinion
Summary of opinion: Tezspire, 18/09/2025 Positive
Human medicines European public assessment report (EPAR): Tuzodi, midazolam, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Omforro, midazolam, Status: Application withdrawn
Summary of opinion: Norvir, 18/09/2025 Positive
Summary of opinion: Uplizna, 18/09/2025 Positive
Summary of opinion: Bimervax, 18/09/2025 Positive
Summary of opinion: Koselugo, 18/09/2025 Positive